Related Experiment Video
Updated: Feb 9, 2026

Identification of Virulence Markers of Mycobacterium abscessus for Intracellular Replication in Phagocytes
Published on: September 27, 2018
Identification and Validation of an Antivirulence Agent Targeting HlyU-Regulated Virulence in Vibrio vulnificus
Saba Imdad1, Akhilesh Kumar Chaurasia1, Kyeong Kyu Kim1
1Department of Molecular Cell Biology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Abstract:
Antimicrobial resistance (AMR) in pathogens is the result of indiscriminate use of antibiotics and consequent metabolic/genetic modulation to evolve survival strategies and clonal-selection in AMR strains. As an alternative to antibiotic treatment, antivirulence strategies are being developed, not only to combat bacterial pathogenesis, but also to avoid emerging antibiotic resistance. Vibrio vulnificus is a foodborne pathogen that causes gastroenteritis, necrotizing wound infections, and sepsis with a high rate of mortality. Here, we developed an inhibitor-screening reporter platform to target HlyU, a master transcriptional regulator of virulence factors in V. vulnificus by assessing rtxA1 transcription under its control. The inhibitor-screening platform includes wild type and ΔhlyU mutant strains of V. vulnificus harboring the reporter construct P ::luxCDABE for desired luminescence signal detection and control background luminescence, respectively. Using the inhibitor-screening platform, we identified a small molecule, fursultiamine hydrochloride (FTH), that inhibits the transcription of the highly invasive repeat-in-toxin (rtxA1) and hemolysin (vvhA) along with other HlyU regulated virulence genes. FTH has no cytotoxic effects on either host cells or pathogen at the tested concentrations. FTH rescues host cells from the necrotic cell-death induced by RtxA1 and decreases the hemolytic activity under in vitro conditions. The most important point is that FTH treatment does not induce the antivirulence resistance. Current study validated the antivirulence strategy targeting the HlyU virulence transcription factor and toxin-network of V. vulnificus and demonstrated that FTH, exhibits a potential to inhibit the pathogenesis of deadly, opportunistic human pathogen, V. vulnificus without inducing AMR.
Insights
Researchers developed a new antivirulence strategy targeting the pathogen Vibrio vulnificus. A small molecule, fursultiamine hydrochloride (FTH), effectively inhibits virulence factors without inducing antimicrobial resistance (AMR).
Area of Science:
- Microbiology and Infectious Diseases
- Drug Discovery and Development
- Antimicrobial Resistance Research
Background:
- Antimicrobial resistance (AMR) is a growing threat driven by antibiotic overuse, necessitating alternative therapeutic strategies.
- Antivirulence approaches target bacterial pathogenicity mechanisms, offering a way to combat infections while mitigating AMR development.
- Vibrio vulnificus is a dangerous foodborne pathogen causing severe illness and high mortality rates.
Purpose of the Study:
- To develop an inhibitor-screening platform targeting HlyU, a key regulator of virulence in Vibrio vulnificus.
- To identify novel compounds that inhibit V. vulnificus virulence without promoting antimicrobial resistance.
- To validate an antivirulence strategy against this opportunistic pathogen.
Main Methods:
- Constructed a reporter platform using wild-type and ΔhlyU mutant V. vulnificus strains with a P_rtxA1::luxCDABE reporter.
- Screened for small molecules inhibiting rtxA1 transcription, a key virulence gene regulated by HlyU.
- Evaluated the efficacy of identified inhibitors on virulence gene expression, cytotoxicity, and hemolytic activity in vitro.
Main Results:
- Identified fursultiamine hydrochloride (FTH) as an inhibitor of HlyU-regulated virulence genes, including rtxA1 and vvhA.
- FTH demonstrated no cytotoxicity to host cells or the pathogen at tested concentrations.
- FTH reduced RTX toxin-induced cell death and hemolytic activity, and importantly, did not induce antivirulence resistance.
Conclusions:
- The study successfully validated an antivirulence strategy targeting the HlyU transcription factor in V. vulnificus.
- Fursultiamine hydrochloride (FTH) effectively inhibits V. vulnificus pathogenesis through targeting virulence factors.
- FTH represents a promising therapeutic candidate for combating V. vulnificus infections without contributing to antimicrobial resistance.
More Related Videos
09:34Development of a More Sensitive and Specific Chromogenic Agar Medium for the Detection of Vibrio parahaemolyticus and Other Vibrio Species
Published on: November 8, 2016
10:21Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
Published on: February 23, 2024
Related Concept Videos
Reliability and Validity
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Regulated mRNA Transport
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...